For many individuals, SSRIs are the first line of defense against depression. But what happens when they don’t work? For millions of patients, this is the reality — despite trying multiple antidepressants, the symptoms remain, or even worsen.

This is called Treatment-Resistant Depression (TRD), and it can leave people feeling defeated. But failure of SSRIs is not a personal failure. Depression is complex, and many people need a different approach.

Why SSRIs Don’t Work for Everyone

SSRIs target serotonin — a single neurotransmitter. However, depression often affects multiple systems in the brain. That’s why some people experience:

  • Emotional numbness

  • No improvement after weeks or months

  • Loss of appetite

  • Fatigue or restlessness

  • Worsening symptoms

If this sounds familiar, you’re not alone — and you’re not out of options.

Spravato®: A New Path When SSRIs Aren’t Enough

Spravato® works on the glutamate system, which plays a major role in mood regulation and brain connectivity. By targeting this pathway, Spravato® can:

  • Restore damaged neural connections

  • Improve mood rapidly

  • Reduce suicidal thoughts

  • Offer relief where traditional medications fail

A Breakthrough Treatment Designed for TRD

Spravato® is FDA-approved specifically for people who have tried 2 or more antidepressants without success. It is not a replacement — it’s a lifeline when traditional methods are not enough.

You Didn’t Fail — Your Medication Did

If SSRIs didn’t help, that doesn’t mean your depression can’t be treated. It simply means you need a different approach, and that approach may be Spravato®.